Related references
Note: Only part of the references are listed.Stimuli-Responsive Microfluidic Interface Enables Highly Efficient Capture and Release of Circulating Fetal Cells for Non-Invasive Prenatal Testing
Huimin Zhang et al.
ANALYTICAL CHEMISTRY (2020)
Highly Sensitive Minimal Residual Disease Detection by Biomimetic Multivalent Aptamer Nanoclimber Functionalized Microfluidic Chip
Yilong Liu et al.
SMALL (2020)
Mechanical segregation and capturing of clonal circulating plasma cells in multiple myeloma using micropillar-integrated microfluidic device
Dongfang Ouyang et al.
BIOMICROFLUIDICS (2019)
Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease
Johannes M. Waldschmidt et al.
SEMINARS IN HEMATOLOGY (2018)
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
Aurore Perrot et al.
BLOOD (2018)
Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders
Brad Foulk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J. Flores-Montero et al.
LEUKEMIA (2017)
Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device
Mohammad A. Qasaimeh et al.
SCIENTIFIC REPORTS (2017)
Multiple Myeloma Cell Drug Responses Differ in Thermoplastic vs PDMS Microfluidic Devices
Thomas A. Moore et al.
ANALYTICAL CHEMISTRY (2017)
Progress and Paradigms in Multiple Myeloma
Kenneth C. Anderson
CLINICAL CANCER RESEARCH (2016)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Share Paper
